Cargando…

Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients

BACKGROUND: A patient's infectivity is determined by the presence of the virus in different body fluids, secretions, and excreta. The persistence and clearance of viral RNA from different specimens of patients with 2019 novel coronavirus disease (COVID-19) remain unclear. This study analyzed th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ling, Yun, Xu, Shui-Bao, Lin, Yi-Xiao, Tian, Di, Zhu, Zhao-Qin, Dai, Fa-Hui, Wu, Fan, Song, Zhi-Gang, Huang, Wei, Chen, Jun, Hu, Bi-Jie, Wang, Sheng, Mao, En-Qiang, Zhu, Lei, Zhang, Wen-Hong, Lu, Hong-Zhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147278/ https://www.ncbi.nlm.nih.gov/pubmed/32118639 http://dx.doi.org/10.1097/CM9.0000000000000774

Ejemplares similares

Dexamethasone/methylprednisolone: Prolongation of the coronavirus disease 2019 viral clearance time: case report
Publicado: (2021)

Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019
por: Kim, Ji-Won, et al.
Publicado: (2021)

Persistent Endothelial Dysfunction in Coronavirus Disease-2019 Survivors Late After Recovery
por: Gao, Yi-Ping, et al.
Publicado: (2022)

Immunosuppressants: Lymphopenia, neutropenia and prolongation of the coronavirus disease 2019 (COVID-19) viral clearance: case report
Publicado: (2021)

Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019
por: Zhao, Hong-Mei, et al.
Publicado: (2020)

Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection
por: Chang, De, et al.
Publicado: (2020)

Host tolerance contributes to persistent viral shedding in COVID-19
por: Chang, De, et al.
Publicado: (2020)

The Association Between the Albumin and Viral Negative Conversion Rate in Patients Infected with Novel Coronavirus Disease 2019 (COVID-19)
por: Lang, Li-wei, et al.
Publicado: (2022)

Future pulmonary rehabilitation perspectives following coronavirus disease 2019 in China
por: Zhao, Hong-Mei, et al.
Publicado: (2021)

Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development
por: Zhu, Wei, et al.
Publicado: (2021)

Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection
por: Thimme, Robert, et al.
Publicado: (2001)

Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2021)

Pulmonary Rehabilitation in Coronavirus Disease 2019 Patients
por: Menekşeoğlu, Ahmet Kıvanç, et al.
Publicado: (2022)

Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP)
por: DU, Hong-Zhi, et al.
Publicado: (2020)

End-to-end automatic differentiation of the coronavirus disease 2019 (COVID-19) from viral pneumonia based on chest CT
por: Song, Jiangdian, et al.
Publicado: (2020)

The Application of Eight-Segment Pulmonary Rehabilitation Exercise in People With Coronavirus Disease 2019
por: Chen, Jian-Min, et al.
Publicado: (2020)

Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19
por: Chang, De, et al.
Publicado: (2020)

Rehabilitation programs for patients with COronaVIrus Disease 2019: consensus statements of Taiwan Academy of Cardiovascular and Pulmonary Rehabilitation
por: Cheng, Yuan-Yang, et al.
Publicado: (2021)

Correction to: End-to-end automatic differentiation of the coronavirus disease 2019 (COVID-19) from viral pneumonia based on chest CT
por: Song, Jiangdian, et al.
Publicado: (2021)

Intra-host analysis of hepaciviral glycoprotein evolution reveals signatures associated with viral persistence and clearance
por: Gömer, André, et al.
Publicado: (2022)

Delayed Clearance of Viral RNA in Sputum for Severity COVID-19 Patients with Initial High Viral Load
por: Zhao, Hong, et al.
Publicado: (2022)

Northern pig-tailed macaques (Macaca leonina) infected with SARS-CoV-2 show rapid viral clearance and persistent immune response
por: Song, Tian-Zhang, et al.
Publicado: (2021)

Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series
por: Cui, Ran, et al.
Publicado: (2021)

Correlation between viral RNA shedding and serum antibodies in individuals with coronavirus disease 2019
por: Jin, C.C., et al.
Publicado: (2020)

Clinical features, laboratory findings and persistence of virus in 10 children with coronavirus disease 2019 (COVID-19)
por: Jiang, Hong, et al.
Publicado: (2021)

Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19)
por: Yang, Lu-Lu, et al.
Publicado: (2020)

Game consumption and the 2019 novel coronavirus
por: Li, Jie, et al.
Publicado: (2020)

Completed absorption of coronavirus disease 2019 (COVID-19) pneumonia lesions: a preliminary study
por: Liu, Xue-yan, et al.
Publicado: (2021)

Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection
por: Martinez, Mario A, et al.
Publicado: (2022)

Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019
por: Xing, Yu-Han, et al.
Publicado: (2020)

Convalescent plasma therapy in critically ill coronavirus disease 2019 patients with persistently positive nucleic acid test, case series report
por: Wang, Min, et al.
Publicado: (2020)

Prolonged viral clearance of severe acute respiratory syndrome coronavirus 2 in the older aged population
por: Ueno, Akitoshi, et al.
Publicado: (2021)

Clinical analysis of prolonged viral clearance time in patients with lymphoma combined with novel coronavirus infection
por: Li, Ying, et al.
Publicado: (2023)

Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance
por: Ghabril, M., et al.
Publicado: (2009)

Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance
por: Shen, Zhongliang, et al.
Publicado: (2017)

Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history
por: Gao, Yinjie, et al.
Publicado: (2020)

Chinese herbal experience for the 2019 novel coronavirus
por: Jiang, Ronglin, et al.
Publicado: (2020)

IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models
por: Shen, Zhongliang, et al.
Publicado: (2019)

The Ethic of Care, Disability, and Rehabilitation During the Coronavirus Disease 2019 Pandemic
por: Russo, Luigi, et al.
Publicado: (2020)

What Now for Rehabilitation Specialists? Coronavirus Disease 2019 Questions and Answers
por: Yonter, Simge J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pi5egh42v67b581vi46fpd0m6i